logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: bioidentical-hormones-market
Load new posts () and activity
Like Reblog Comment
text 2019-11-26 14:30
Bioidentical Hormones Market Analysis, Latest Innovations, Research, Segment, Growth Prediction, Industry Trends, Upcoming Trends And Opportunity Assessment

Global bioidentical hormones market is expected to reach USD 400 million by 2023, and the market is projected to grow at a CAGR of 5.2 % during the forecast period 2017-2023.

 

Bioidentical Hormones Market Overview

Bioidentical hormones although are created in a lab they are very similar to the hormones produced by the human body.  Hence, they can be defined as man-made hormones. These hormones are customized as per the prescription or are compounded by a pharmacist, based on the doctor’s demand. 

 

Bioidentical hormones are then used as a treatment for people whose own hormones are imbalanced. Bioidentical hormones just as hormones produced by the human body can control almost all tasks in the body including sex and brain function, growth and the breakdown of food, etc.

 

Hormonal imbalance can cause increased risks including low energy, weight gain, muscle atrophy, hair loss, depression, anxiety, mood swings, trouble sleeping, and hot/ cold flashes & night sweats for women who are going through their menopause.

People witnessing these symptoms are prescribed with the hormone-replacement therapy where the provider first talks with the patients and asks them to undergo a blood test to determine the specific symptoms and then orders the test.

 

Get Free PDF Sample Of Bioidentical Hormones Market Research Report- Global Forecast till 2023 https://www.marketresearchfuture.com/sample_request/4187

 

Unlike, the synthetic hormones, bio-identical hormones do not create any cause side effects and increased risks. These hormones rarely have side effects and, if they do, the provider might need to adjust the dosage. As a result, bio-identical hormones are preferred widely.

 

Increasing prevalence of hormonal changes or imbalance in hormones led by the sedentary lifestyle, lack of nutrition, and the aging drives the market for bioidentical hormones, creating a huge demand.  Resultantly, the bioidentical hormones market garners huge demand, uptake, and hence the colossal growth on the global platform.

Recognizing the kind of the growth, the market witnesses today, an eminent research firm, Market Research Future (MRFR) in its recently published study report confirms that the global bioidentical hormones market will reach USD 400 MN, registering approximately 5.2 % CAGR during the forecast period (2017-2023).

 

Additional factors substantiating the market growth include the environmental changes, increasing industrialization and urbanization. Improving economic conditions are certainly providing a vast impetus to the market growth, availing the quality healthcare.

On the other hand, factors such as the demand and supply gap of feedstock required in the production of these hormones are estimated to obstruct the market growth over the forecast period, increasing their prices unreasonably. 

 

Bioidentical Hormones Global Market – Segmentations

MRFR has segmented the report into four key dynamics for an easy grasp; 

By Types : Estrogens, Progesterone, and Testosterone among others.

By Product Types: Tablets & Capsules, Creams & Gels, Injectable, and Patches & Implants among others.

By End-Users: Hospitals & Gynecology Clinics, Academic and Research among others.

By RegionsEurope, North America, APAC and the Rest-of-the-World. 

 

Global Bioidentical Hormones Market – Regional Analysis

The North American region dominates the global bioidentical hormones market, in terms of both market size as well as revenue. The extensive use of medications and high expenditure on health care majorly lead the market growth in the region.  Besides, factors such as the fastest uptake of new drugs alongside the presence of major research companies drive the bioidentical hormones market in the region.

 

The European region accounts for the second-largest market in the world due to high per capita income and healthcare expenditures. A well-developed healthcare sector along with the resurging economy in the region substantiates the market growth of bioidentical hormones in the region. Some of the European countries such as the U.K, Germany, and France boost the market growth in this region.

 

The Asia Pacific region accounts for a promising market for bioidentical hormones, closely following the European market. Factors such as the ever-increasing population encourage the use to bioidentical hormones, creating a significant demand for healthcare. China and India backed by their respective, fast-growing healthcare sector will be leading the APAC bioidentical hormones market. 

 

Global Bioidentical Hormones Market – Competitive Analysis

Highly competitive bioidentical hormones market appears fragmented due to the presence of several large and small-scale players. Producers compete based upon price and brand, emphasizing upon new product development initiatives, and geographical expansion. Matured players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain a competitive advantage and thus to maintain their positions in this market.

 

Key Players:

Some of the eminent leaders of the market include BioTE Medical, SottoPelle, Advantage Pharmaceuticals, Inc., Neuva Aesthetics, Full Life Wellness Center, Defy Medical, and Biostation.

 

Industry/ Innovation/ Related News:

October 29, 2018 – TherapeuticsMD Inc. (US) a leading global Pharmaceutical company announced receiving its third FDA approval of the year, Bijuva, a menopause remedy that combines two bioidentical hormones.

 

Bijuva, an oral soft gel that contains ingredients are artificially produced but chemically identical to hormones made naturally by women's bodies such as estradiol and progesterone which are commonly used in hormone therapies to treat menopause symptoms such as hot/cold flashes. The company is now all geared up to launch first-ever bioidentical hormone combo Bijuva.

 

Browse the market data and information spread across 80 pages with data tables and figures of the report “Bioidentical Hormones Market Information: By Types (Estrogens, Progesterone, Testosterone, others) By Product Types (Tablets and Capsules, Creams and Gels, Injectable, Patches and Implants, and others) By End Users Global Forecast Till 2023” in-depth alongside table of content (TOC) at:  https://www.marketresearchfuture.com/reports/bioidentical-hormones-market-4187

Like Reblog Comment
text 2018-12-26 09:05
Bioidentical Hormones Market

Bioidentical hormones are hormones that are chemically the same as those that the body produces. Although they are made in a laboratory, bioidentical hormones mimic the hormones the human body produces naturally.
The global Bioidentical Hormones market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 20192025. The objectives of this study are to define, segment, and project the size of the Bioidentical Hormones market based on company, product type, end user and key regions.

This report studies the global market size of Bioidentical Hormones in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bioidentical Hormones in these regions.
This research report categorizes the global Bioidentical Hormones market by top players/brands, region, type and end user. This report also studies the global Bioidentical Hormones market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
SottoPelle
BioTE Medical
Advantage Pharmaceuticals
Full Life Wellness Center
Neuva Aesthetics
Defy Medical
Biostation

Market size by Product
Estrogens
Progesterone
Testosterone
Others
Market size by End User
Hospitals & gynecology clinics
Academic and research
Others

Market size by Region
North America
United States
Canada
Mexico
AsiaPacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Bioidentical Hormones market size value & volume by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bioidentical Hormones market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industryspecific challenges and risks.
Focuses on the key global Bioidentical Hormones companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bioidentical Hormones submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bioidentical Hormones are as follows:
History Year: 20142018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value million US$ and volume K Units. Both topdown and bottomup approaches have been used to estimate and validate the market size of Bioidentical Hormones market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Source: www.qandqmarketresearch.com
More posts
Your Dashboard view:
Need help?